Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

NCT01750437 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-erosive Reflux Disease

Interventions

DRUG: YH1885L(Revaprazan)
DRUG: Esomeprazole 20mg
DRUG: placebo

Sponsor

Yuhan Corporation